Oxygen regulation of gene expression: A study in opposites

Molecular Genetics and Metabolism

Volumn 71, Issue 1-2, 2000, Pages 371-380

  D'Angio, Carl T ^a   Finkelstein, Jacob N ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Gene regulation; Hyperoxia; Hypoxia; Hypoxia inducible factor 1; Nuclear factor B; Oxygen injury; Reactive oxygen species; Transcription factors; Von Hippel Lindau disease

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VASCULOTROPIN;

ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; INTRON; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY;

EID: 0033808725     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3074     Document Type: Article

References (73)

1. Repression of gene expression by oxidative stress
2. Peroxynitrite: A biologically significant oxidant
3. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid
4. Antioxidant functions of vitamins: Vitamins E and C, beta-carotene, and other carotenoids
5. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: Role in EGF receptor-mediated tyrosine phosphorylation
6. Angiogenesis in cancer, vascular, rheumatoid and other disease
7. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
8. Purification and characterization of hypoxia-inducible factor 1
9. Remembrance of things PAS: Regulation of development by bHLH-PAS proteins
10. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain
11. In vivo expression of mRNAs encoding hypoxia-inducible factor 1
12. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway
13. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: Its stabilization by hypoxia depends on redox-induced changes
14. Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
15. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein
16. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression
17. Arterial oxygen partial pressures reduce the insulin-dependent induction of the perivenously located glucokinase in rat hepatocyte cultures: Mimicry of arterial oxygen pressures by H202
18. Role of oxygen in the zonation of carbohydrate metabolism and gene expression in liver
19. Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells
20. Role of hydrogen peroxide in hypoxia-induced erythropoietin production
21. Cytochromes and oxygen radicals as putative members of the oxygen sensing pathway
22. Hypoxia-inducible factor 1alpha (HIF-1alpha) is a non-heme iron protein: Implications for oxygen sensing
23. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
24. 2-sensing cells
25. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
26. Effects of pro- and antioxidative compounds on renal production of erythropoietin
27. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
28. Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy
29. Retinal VEGF in situ mRNA expression during active and post-cryotherapy retinopathy of prematurity (ROP) in human infants
30. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
31. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
32. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells
33. von Hippel-Lindau syndrome: Target for antivascular endothelial growth factor (VEGF) receptor therapy
34. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
35. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
36. Oxygen toxicity in neonatal and adult animals of various species
37. Interleukin-8 and monocyte chemoattractant protein-1 mRNAs in oxygen-injured rabbit lung
38. Chemokine mRNA alterations in newborn and adult mouse lung during acute hyperoxia
39. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit
40. Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties
41. Hyperoxia synergistically increases TNF-alpha-induced interleukin-8 gene expression in A549 cells
42. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome
43. Oxidative stress and gene regulation
44. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries
45. Multiple redox regulation in NF-kappaB transcription factor activation
46. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105
47. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
48. Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304: Lack of involvement of H202 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells
49. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B
50. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B
51. Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress
52. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway
53. HIV-1 promoter activation following an oxidative stress mediated by singlet oxygen
54. Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates
55. Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H202 and tumor necrosis factor-alpha in endothelial and epithelial cells
56. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: Requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants
57. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B
58. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation
59. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappaB and AP-1
60. Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells
61. Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells
62. Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes
63. Effects of lisofylline on hyperoxia-induced lung injury
64. O2-induced ENaC expression is associated with NF-kappaB activation and blocked by superoxide scavenger
65. Modulation of monocyte chemotactic protein-1 production by hyperoxia: Importance of RNA stability in control of cytokine production
66. Effect of hyperoxia on human macrophage cytokine response
67. Hyperoxia and lung disease
68. Bronchopulmonary dysplasia: Twenty-five years later
69. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
70. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease
71. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome
72. NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome
73. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells